- Written by ClinicalTrials.gov
- Category: Bone diseases
Intervention: Drug: KRN23
Sponsors: Kyowa Hakko Kirin Pharma, Inc.; Kyowa Hakko Kirin Company, Limited
Recruiting - verified August 2011
- Details
Improving orthopaedic care, education and research using Internet technologies
© 1999-2017 Orthogate. All rights reserved.